POET Fundamental Analysis - POET TECHNOLOGIES INC

Fundamental Rating

Overall POET gets a fundamental rating of 2 out of 10. We evaluated POET against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of POET have multiple concerns. While showing a medium growth rate, POET is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year POET has reported negative net income.

POET had a negative operating cash flow in the past year.

In the past 5 years POET always reported negative net income.

POET had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

POET has a Return On Assets of -60.13%. This is amonst the worse of the industry: POET underperforms 89.29% of its industry peers.

Looking at the Return On Equity, with a value of -109.23%, POET is doing worse than 89.29% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-60.13%
ROE	-109.23%
ROIC	N/A

ROA(3y)-149.67%

ROA(5y)-132.57%

ROE(3y)-289.59%

ROE(5y)-248.85%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for POET so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

POET does not have a ROIC to compare to the WACC, probably because it is not profitable.

POET has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, POET has more shares outstanding

Compared to 1 year ago, POET has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.33 indicates that POET is not a great score, but indicates only limited risk for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 2.33, POET is doing worse than 62.50% of the companies in the same industry.

POET has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.

With a Debt to Equity ratio value of 0.15, POET perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	2.33

ROIC/WACCN/A

WACC10.77%

2.3 Liquidity

A Current Ratio of 1.89 indicates that POET should not have too much problems paying its short term obligations.

The Current ratio of POET (1.89) is worse than 75.89% of its industry peers.

POET has a Quick Ratio of 1.89. This is a normal value and indicates that POET is financially healthy and should not expect problems in meeting its short term obligations.

With a Quick ratio value of 1.89, POET perfoms like the industry average, outperforming 43.75% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.89
Quick Ratio	1.89

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

POET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.46%.

POET shows a strong growth in Revenue. In the last year, the Revenue has grown by 302.41%.

Measured over the past years, POET shows a very negative growth in Revenue. The Revenue has been decreasing by -41.80% on average per year.

EPS 1Y (TTM)-38.46%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-35.71%

Revenue 1Y (TTM)302.41%

Revenue growth 3Y-41.8%

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

POET is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.42% yearly.

The Revenue is expected to grow by 1159.92% on average over the next years. This is a very strong growth

EPS Next Y69.52%

EPS Next 2Y34.19%

EPS Next 3Y31.42%

EPS Next 5YN/A

Revenue Next Year2770.59%

Revenue Next 2Y1314.21%

Revenue Next 3Y1159.92%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

POET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year POET is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as POET's earnings are expected to grow with 31.42% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y34.19%

EPS Next 3Y31.42%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for POET!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

POET TECHNOLOGIES INC

NASDAQ:POET (9/18/2025, 8:16:02 PM)

Premarket: 5.29 +0.05 (+1.05%)

5.235

+0.1 (+1.85%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSemiconductors & Semiconductor Equipment

GICS IndustrySemiconductors & Semiconductor Equipment

Earnings (Last)08-11 2025-08-11/amc

Earnings (Next)11-12 2025-11-12

Inst Owners3.35%

Inst Owner Change231.68%

Ins Owners0.73%

Ins Owner ChangeN/A

Market Cap475.02M

Analysts82.86

Price Target6.77 (29.32%)

Short Float %6.69%

Short Ratio2.86

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)75.66%

Min EPS beat(2)-69.34%

Max EPS beat(2)220.66%

EPS beat(4)1

Avg EPS beat(4)-137.32%

Min EPS beat(4)-569.93%

Max EPS beat(4)220.66%

EPS beat(8)1

Avg EPS beat(8)-81.46%

EPS beat(12)5

Avg EPS beat(12)-50.94%

EPS beat(16)7

Avg EPS beat(16)-39.03%

Revenue beat(2)0

Avg Revenue beat(2)-31.96%

Min Revenue beat(2)-59.13%

Max Revenue beat(2)-4.8%

Revenue beat(4)0

Avg Revenue beat(4)-50.12%

Min Revenue beat(4)-93.46%

Max Revenue beat(4)-4.8%

Revenue beat(8)1

Avg Revenue beat(8)-48.45%

Revenue beat(12)2

Avg Revenue beat(12)-24.04%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)18.18%

EPS NQ rev (3m)-50%

EPS NY rev (1m)0%

EPS NY rev (3m)-8.33%

Revenue NQ rev (1m)-20%

Revenue NQ rev (3m)-63.64%

Revenue NY rev (1m)-58.31%

Revenue NY rev (3m)-66%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1015.01
P/FCF	N/A
P/OCF	N/A
P/B	9.62
P/tB	9.74
EV/EBITDA	N/A

EPS(TTM)-0.72

EYN/A

EPS(NY)-0.17

Fwd EYN/A

FCF(TTM)-0.42

FCFYN/A

OCF(TTM)-0.34

OCFYN/A

SpS0.01

BVpS0.54

TBVpS0.54

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-60.13%
ROE	-109.23%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-149.67%

ROA(5y)-132.57%

ROE(3y)-289.59%

ROE(5y)-248.85%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.01

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	303.36%
Cap/Sales	1634.06%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.89
Quick Ratio	1.89
Altman-Z	2.33

F-Score5

WACC10.77%

ROIC/WACCN/A

Cap/Depr(3y)216.1%

Cap/Depr(5y)184.86%

Cap/Sales(3y)5894.23%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-38.46%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-35.71%

EPS Next Y69.52%

EPS Next 2Y34.19%

EPS Next 3Y31.42%

EPS Next 5YN/A

Revenue 1Y (TTM)302.41%

Revenue growth 3Y-41.8%

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year2770.59%

Revenue Next 2Y1314.21%

Revenue Next 3Y1159.92%

Revenue Next 5YN/A

EBIT growth 1Y-56.37%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-16.58%

EBIT Next 3Y40.56%

EBIT Next 5YN/A

FCF growth 1Y-139.79%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-125.79%

OCF growth 3YN/A

OCF growth 5YN/A

POET TECHNOLOGIES INC (POET) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens